查看購物車
  • Simplified Chinese
  • English
2021-2031年北美栓塞器材市場報告：範圍、細分、動態與競爭分析
市場調查報告書
商品編碼
1871489

2021-2031年北美栓塞器材市場報告：範圍、細分、動態與競爭分析

North America Embolization Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 181 Pages | 訂單完成後即時交付

價格

預計北美栓塞器械市場將大幅成長，到 2031 年將達到約 24.0442 億美元，高於 2024 年的 12.426 億美元，2025 年至 2031 年的年複合成長率(CAGR) 預計為 10.0%。

執行摘要和市場分析

北美栓塞器械市場的成長得益於該地區先進的醫療保健體系、血管疾病發病率的上升以及人們對微創手術日益成長的偏好。技術創新大大提高了栓塞技術的精準性和安全性，使其成為治療動脈瘤、動靜脈畸形和腫瘤等疾病的首選方法。患者對疾病和治療方案的高度認知、完善的醫療報銷體係以及領先醫療器材製造商的存在，共同推動了北美栓塞器材市場的成熟。公共衛生措施在推廣栓塞手術方面也發揮著至關重要的作用。持續的研究和臨床試驗正在拓展栓塞技術的應用範圍，特別關注可生物分解和藥物洗脫栓塞劑。儘管美國在栓塞器械的應用和創新方面處於領先地位，但加拿大和墨西哥正透過扶持政策和基礎設施的改善，逐步提升其市場佔有率。然而，城鄉醫療資源分配不均仍是一項挑戰。該地區持續吸引醫院、研究機構和設備製造商之間的大量投資和合作，從而確保栓塞技術的持續發展和創新。

市場區隔分析

北美栓塞器械市場可按類型、應用和最終用戶進行細分。

  • 依類型分類：市場產品包括栓塞線圈、栓塞塞、栓塞珠、栓塞膠等。 2024年，栓塞線圈佔據最大的市場佔有率，並進一步細分為中心栓塞和周邊栓塞。
  • 按應用領域分類：市場分為神經病學、周邊血管疾病、腫瘤學、泌尿學和其他領域，其中神經病學在 2024 年將成為領先領域。
  • 按最終用戶分類：市場分為醫院、門診中心和其他，到 2024 年，醫院將佔據市場佔有率的主導地位。

市場展望

諸如改進的導管設計、新型栓塞劑和可脫卸彈簧圈等創新技術提高了栓塞手術的療效和安全性。例如，血流導向裝置透過將血流從動脈瘤囊引流，促進動脈瘤內血栓形成，徹底改變了複雜顱內動脈瘤的治療方法。臨床研究對於推進栓塞技術至關重要，有助於擴大適應症範圍並改善患者預後。由Fluidx Medical Technology公司開發的IMPASS栓塞彈簧圈裝置透過栓塞腦膜中動脈，在治療慢性硬腦膜下血腫方面展現出良好的前景，體內研究也證實了其有效性。美國FDA於2024年5月批准了Fluidx公司的GPX栓塞裝置的研究性器械豁免（IDE）申請，相關積極結果發表在《血管與介入放射學雜誌》上，表明該裝置具有很高的技術成功率和良好的臨床評價。

在首次人體試驗中評估的Caterpillar動脈栓塞系統，證實其能有效閉塞周邊動脈，且嚴重不良事件風險極低。隨著市場的發展，臨床研究與器材創新之間的合作對於滿足日益成長的有效栓塞療法需求至關重要。將臨床研究融入栓塞器械的研發正成為重要趨勢，可望拓展治療選擇並改善病患預後。

國家概況

北美栓塞器械市場涵蓋美國、加拿大和墨西哥，其中美國在2024年佔據最大的市場佔有率。美國市場的特點是創新水平高、新技術應用迅速，並且高度重視微創治療。微創手術（MIS）的趨勢日益成長，醫療機構傾向於採用栓塞術治療肝細胞癌（HCC）、子宮肌瘤和腦動脈瘤等疾病，因為與傳統手術相比，栓塞術風險更低、恢復更快。美國市場受益於對醫療技術的巨額投資以及強力的臨床研究，這些都支持栓塞療法的有效性。

公司簡介

栓塞器械市場的主要參與者包括美敦力、庫克醫療、史賽克、波士頓科學、泰爾茂、強生、雅培等。這些公司正透過擴張、產品創新、併購等策略來提升市場佔有率並提供創新產品。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基數：
    • 數據三角測量：
    • 國家層面資料：
  • 假設和局限性

第4章：北美栓塞器材市場概況

  • 概述
  • PEST分析
  • 定價分析
    • 主要品牌定價分析

第5章：北美栓塞器材市場－主要市場動態

  • 北美栓塞器材市場－主要市場動態
  • 市場促進因素
    • 臨床疾病盛行率上升
    • 對微創技術的需求日益成長
  • 市場限制
    • 栓塞術期間或之後出現的併發症
  • 市場機遇
    • 新產品開發及市場推廣核准
  • 未來趨勢
    • 透過臨床創新變革栓塞治療
  • 駕駛員和安全帶的影響：

第6章：栓塞器械市場－北美分析

  • 2021-2031年北美栓塞器材市場收入
  • 北美栓塞器材市場預測分析

第7章：北美栓塞器材市場分析－依產品類型分類

  • 栓塞線圈
  • 插頭
  • 珠
  • 膠水
  • 其他

第8章：北美栓塞器材市場分析－依應用領域分類

  • 神經病學
  • 周邊血管疾病
  • 腫瘤學
  • 泌尿科
  • 其他

第9章：北美栓塞器材市場分析－依最終使用者分類

  • 醫院
  • 門診中心
  • 其他

第10章：北美栓塞器材市場－國別分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第11章：競爭格局

  • 關鍵參與者熱力圖分析
  • 公司定位與集中度

第12章：行業概況

  • 概述
  • 擴張
  • 新產品開發與核准
  • 併購
  • 夥伴關係與合作

第13章：公司簡介

  • Medtronic Plc
  • Cook Medical Holdings LLC
  • Stryker Corp
  • Boston Scientific Corp
  • Terumo Corp
  • Johnson & Johnson
  • Abbott Laboratories
  • NeuroSafe Medical Co. Ltd
  • Wallaby Medical
  • Sirtex Medical Ltd
  • GEM srl
  • Penumbra Inc.
  • Balt
  • Lepu Medical Technology Beijing Co Ltd
  • INVAMED
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Lifetech Scientific Corp

第14章：附錄

Product Code: BMIRE00032146

The North America embolization devices market is projected to grow significantly, reaching approximately US$ 2,404.42 million by 2031, up from US$ 1,242.60 million in 2024, with an estimated compound annual growth rate (CAGR) of 10.0% from 2025 to 2031.

Executive Summary and Market Analysis

The growth of the embolization devices market in North America is fueled by the region's advanced healthcare systems, rising incidence of vascular diseases, and an increasing preference for minimally invasive procedures. Technological innovations have greatly improved the precision and safety of embolization techniques, making them the preferred treatment for conditions like aneurysms, arteriovenous malformations, and tumors. High levels of patient awareness regarding medical conditions and treatment options, robust healthcare reimbursement frameworks, and the presence of leading medical device manufacturers contribute to the market's maturity in North America. Public health initiatives also play a vital role in promoting embolization procedures. Ongoing research and clinical trials are expanding the applications of embolization technologies, particularly focusing on biodegradable and drug-eluting embolic agents. While the United States leads in adoption and innovation, Canada and Mexico are gradually enhancing their market presence through supportive policies and infrastructure improvements. However, disparities in healthcare access between urban and rural areas pose challenges. The region continues to attract significant investments and collaborations among hospitals, research institutions, and device manufacturers, ensuring ongoing development and innovation in embolization technologies.

Market Segmentation Analysis

The North America embolization devices market can be segmented by type, application, and end user.

  • By Type: The market includes embolization coils, plugs, beads, glues, and others. In 2024, embolization coils held the largest market share, further divided into central and peripheral applications.
  • By Application: The market is categorized into neurology, peripheral vascular disease, oncology, urology, and others, with neurology being the leading segment in 2024.
  • By End User: The market is segmented into hospitals, ambulatory centers, and others, with hospitals dominating the market share in 2024.

Market Outlook

Innovations such as enhanced catheter designs, new embolic agents, and detachable coils have improved the efficacy and safety of embolization procedures. For instance, flow-diverting devices have transformed the treatment of complex intracranial aneurysms by redirecting blood flow away from the aneurysm sac, promoting thrombosis within the aneurysm. Clinical studies are crucial for advancing embolization techniques, leading to broader indications and better patient outcomes. The IMPASS embolic coil device, developed by Fluidx Medical Technology, has shown promise in treating chronic subdural hematomas by embolizing the middle meningeal artery, with in-vivo studies demonstrating its effectiveness. The US FDA granted Investigational Device Exemption (IDE) approval for Fluidx's GPX embolic device in May 2024, with positive results published in the Journal of Vascular and Interventional Radiology, indicating high technical success and favorable physician feedback.

The Caterpillar Arterial Embolization System, assessed in a first-in-human study, demonstrated effective occlusion in peripheral arteries with minimal risk of serious adverse events. As the market evolves, the collaboration between clinical research and device innovation will be essential in meeting the increasing demand for effective embolization therapies. Integrating clinical studies into the development of embolization devices is emerging as a significant trend, leading to expanded treatment options and improved patient outcomes.

Country Insights

The North America embolization devices market includes the US, Canada, and Mexico, with the US holding the largest market share in 2024. The US market is characterized by high innovation levels, early adoption of new technologies, and a strong focus on minimally invasive treatments. The trend towards minimally invasive surgeries (MIS) has been increasing, with healthcare providers favoring embolization procedures for conditions like hepatocellular carcinoma (HCC), uterine fibroids, and brain aneurysms due to their lower risk and quicker recovery times compared to traditional surgeries. The US market benefits from substantial investments in medical technology and robust clinical research supporting the efficacy of embolization therapies.

Company Profiles

Key players in the embolization devices market include Medtronic, Cook Medical, Stryker, Boston Scientific, Terumo, Johnson & Johnson, Abbott Laboratories, and others. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. North America Embolization Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Pricing Analysis
    • 4.3.1 Pricing Analysis by Key Brands

5. North America Embolization Devices Market - Key Market Dynamics

  • 5.1 North America Embolization Devices Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Clinical Conditions
    • 5.2.2 Burgeoning Demand for Minimally Invasive Techniques
  • 5.3 Market Restraints
    • 5.3.1 Complications Arising During or After Embolization
  • 5.4 Market Opportunities
    • 5.4.1 New Product Developments and Marketing Approvals
  • 5.5 Future Trends
    • 5.5.1 Transforming Embolization Through Clinical Innovation
  • 5.6 Impact of Drivers and Restraints:

6. Embolization Devices Market - North America Analysis

  • 6.1 North America Embolization Devices Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Embolization Devices Market Forecast Analysis

7. North America Embolization Devices Market Analysis - by Product Type

  • 7.1 Embolization Coils
    • 7.1.1 Overview
    • 7.1.2 Embolization Coils: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Plugs
    • 7.2.1 Overview
    • 7.2.2 Plugs: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Beads
    • 7.3.1 Overview
    • 7.3.2 Beads: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Glues
    • 7.4.1 Overview
    • 7.4.2 Glues: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Embolization Devices Market Analysis - by Application

  • 8.1 Neurology
    • 8.1.1 Overview
    • 8.1.2 Neurology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Peripheral Vascular Disease
    • 8.2.1 Overview
    • 8.2.2 Peripheral Vascular Disease: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Urology
    • 8.4.1 Overview
    • 8.4.2 Urology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Embolization Devices Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Ambulatory Centers
    • 9.2.1 Overview
    • 9.2.2 Ambulatory Centers: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Embolization Devices Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Embolization Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Embolization Devices Market Share - by Product Type
        • 10.1.1.2.2 United States: North America Embolization Devices Market Share - by Embolization Coils
        • 10.1.1.2.3 United States: North America Embolization Devices Market Share - by Application
        • 10.1.1.2.4 United States: North America Embolization Devices Market Share - by End User
      • 10.1.1.3 Canada: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Embolization Devices Market Share - by Product Type
        • 10.1.1.3.2 Canada: North America Embolization Devices Market Share - by Embolization Coils
        • 10.1.1.3.3 Canada: North America Embolization Devices Market Share - by Application
        • 10.1.1.3.4 Canada: North America Embolization Devices Market Share - by End User
      • 10.1.1.4 Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Embolization Devices Market Share - by Product Type
        • 10.1.1.4.2 Mexico: North America Embolization Devices Market Share - by Embolization Coils
        • 10.1.1.4.3 Mexico: North America Embolization Devices Market Share - by Application
        • 10.1.1.4.4 Mexico: North America Embolization Devices Market Share - by End User

11. Competitive Landscape

  • 11.1 Heat Map Analysis by Key Players
  • 11.2 Company Positioning and Concentration

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Expansion
  • 12.3 New Product Development and Approval
  • 12.4 Merger and Acquisition
  • 12.5 Partnerships and Collaboration

13. Company Profiles

  • 13.1 Medtronic Plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Cook Medical Holdings LLC
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Stryker Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Boston Scientific Corp
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Terumo Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Johnson & Johnson
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Abbott Laboratories
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 NeuroSafe Medical Co. Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Wallaby Medical
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Sirtex Medical Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 GEM srl
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Penumbra Inc.
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Balt
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Lepu Medical Technology Beijing Co Ltd
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 INVAMED
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Meril Life Sciences Pvt Ltd
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Merit Medical Systems Inc
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Lifetech Scientific Corp
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Embolization Devices Market Segmentation
  • Table 2. Pricing Analysis by Key Brands
  • Table 3. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 4. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 5. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 6. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 7. North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 8. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 9. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 10. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 11. United States: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 12. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 13. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 14. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 15. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 16. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
  • Table 17. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Embolization Coils
  • Table 18. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
  • Table 19. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
  • Table 20. Glossary of Terms, Embolization Devices Market

List Of Figures

  • Figure 1. North America Embolization Devices Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Embolization Devices Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Embolization Devices Market Share (%) - by Product Type (2024 and 2031)
  • Figure 6. Embolization Coils: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Plugs: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Beads: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Glues: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. North America Embolization Devices Market Share (%) - by Application (2024 and 2031)
  • Figure 12. Neurology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Peripheral Vascular Disease: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Oncology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Urology: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. North America Embolization Devices Market Share (%) - by End User (2024 and 2031)
  • Figure 18. Hospitals: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Ambulatory Centers: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: North America Embolization Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. North America Embolization Devices Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 22. United States: North America Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Canada: North America Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Mexico: North America Embolization Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Heat Map Analysis by Key Players
  • Figure 26. Company Positioning and Concentration